Cargando…
Sepsis mediators
During sepsis, the plasma levels of numerous inflammatory markers are enhanced. Some of these markers are the mediators responsible for the syndromes observed during sepsis as well as for organ dysfunction and eventually death. Their role has been demonstrated in experimental models that employed ei...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102023/ https://www.ncbi.nlm.nih.gov/pubmed/17880845 http://dx.doi.org/10.1007/s11908-007-0056-6 |
_version_ | 1783511737756024832 |
---|---|
author | Philippart, François Cavaillon, Jean-Marc |
author_facet | Philippart, François Cavaillon, Jean-Marc |
author_sort | Philippart, François |
collection | PubMed |
description | During sepsis, the plasma levels of numerous inflammatory markers are enhanced. Some of these markers are the mediators responsible for the syndromes observed during sepsis as well as for organ dysfunction and eventually death. Their role has been demonstrated in experimental models that employed either transgenic and gene-targeted animals or the use of neutralizing agents. Accordingly, anaphylatoxins generated after complement system activation, factors of coagulation and fibrinolysis, proinflammatory cytokines, chemokines, proteases, lipid mediators, nitric oxide, and cell markers of stress (eg, high mobility group box-1) have been shown to contribute to the deleterious events observed during sepsis. On the other hand, the counterregulation of the inflammatory process, which involves mediators such as anti-inflammatory cytokines and some neuromediators, can jeopardize the immune status of the host and render the patients more sensitive to nosocomial infections. |
format | Online Article Text |
id | pubmed-7102023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Current Science Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71020232020-03-31 Sepsis mediators Philippart, François Cavaillon, Jean-Marc Curr Infect Dis Rep Article During sepsis, the plasma levels of numerous inflammatory markers are enhanced. Some of these markers are the mediators responsible for the syndromes observed during sepsis as well as for organ dysfunction and eventually death. Their role has been demonstrated in experimental models that employed either transgenic and gene-targeted animals or the use of neutralizing agents. Accordingly, anaphylatoxins generated after complement system activation, factors of coagulation and fibrinolysis, proinflammatory cytokines, chemokines, proteases, lipid mediators, nitric oxide, and cell markers of stress (eg, high mobility group box-1) have been shown to contribute to the deleterious events observed during sepsis. On the other hand, the counterregulation of the inflammatory process, which involves mediators such as anti-inflammatory cytokines and some neuromediators, can jeopardize the immune status of the host and render the patients more sensitive to nosocomial infections. Current Science Inc. 2007-09-11 2007 /pmc/articles/PMC7102023/ /pubmed/17880845 http://dx.doi.org/10.1007/s11908-007-0056-6 Text en © Current Medicine Group LLC 2007 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Philippart, François Cavaillon, Jean-Marc Sepsis mediators |
title | Sepsis mediators |
title_full | Sepsis mediators |
title_fullStr | Sepsis mediators |
title_full_unstemmed | Sepsis mediators |
title_short | Sepsis mediators |
title_sort | sepsis mediators |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102023/ https://www.ncbi.nlm.nih.gov/pubmed/17880845 http://dx.doi.org/10.1007/s11908-007-0056-6 |
work_keys_str_mv | AT philippartfrancois sepsismediators AT cavaillonjeanmarc sepsismediators |